10 Unusual Stocks Attracting Huge Interest In The Pre-Market Right Now

radar war

Photo: Wikimedia Commons

Here’s were we see the heat today:America’s first ever stem cell trial begins, two companies plummet as executives resign, Intel earnings, and more…

EARNINGS: Intel (INTC) reports after the market close

EARNINGS: Railroad CSX (CSX) reports after the market close

M&A: Actividentity is being bought out for $3.25 per share.

Geron (GERN) starts first trial of stem cell treatment in America

EARNINGS: Posco Steel (PKX) reports a fall in sales, rise in costs, ADR shares dropping

CEO RESIGNATION: Synaptics (SYNA) CEO leaves company for 'personal reasons', stock dropping

ODD: Chinese autopart producer Tongxin (TXIC) crashing in the pre-market

Down over 13%.

M&A: Pfizer (PFE) is buying King Pharmaceuticals (KG), King spikes 40%

It's a $14.25 per share, all cash deal. Read about it here.

RESIGNATION: For-profit education company Corinthian (COCO) is dropping again as President & COO resigns

MedQuist (MEDQ) losing even more of its recent gains

They recenlty provided an update on their upcoming special dividend. Read about it here.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.